Warfarin therapy does not increase risk of symptomatic intracerebral hemorrhage in eligible patients after intravenous thrombolysis.
Levin D, Smith DB, Cumbler E, Carter J, Glasheen JJ, Jones W. Warfarin therapy does not increase risk of symptomatic intracerebral hemorrhage in eligible patients after intravenous thrombolysis. Arch Neurol. 2011 Jan; 68(1):135; author reply 135-6.